2011•Clinical Lymphoma Myeloma & LeukemiaRequires access

4.19 Prediction of Poor Outcome in Chronic Lymphocytic Leukemia Patients treated with FCR (Fludarabine, Cyclophosphamide, Rituximab) in the CLL8 Trial of the German CLL Study Group

Anna Maria Fink, Raymonde Busch, Natali Pflug, Sebastian Böettcher, Dirk Winkler, Andreas Buehler, Matthias Ritgen, Kirsten Fischer, Barbara Eichhorst, Clemens‐Martin Wendtner, Myriam Mendila, Michael Wenger, Hartmut Doehner, Michael Kneba, Stephan Stilgenbauer, Michael Hallek

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fludarabine, Chronic lymphocytic leukemia, Rituximab, Cyclophosphamide, Medicine, Internal medicine, Oncology, Randomization